摘要
目的omega-3多不饱和脂肪酸二十碳五烯酸(eicosapentaenoic acid,EPA)和二十二碳六烯酸(docosahexaenoic acid,DHA)能够抑制M1型小胶质细胞的过度激活促炎细胞因子的释放和细胞凋亡,而EPA具有抗抑郁的作用。与EPA比较,DHA似对记忆的改善作用更强。由于两者在食物、衰老和疾病中的比值多变,其单一和最佳组合的功效不明,本实验拟利用AD模型比较研究EPA、DHA及最佳组合改善认知障碍及神经炎症的机制。方法Al 3+诱导斑马鱼AD模型,饲予EPA、DHA或EPA+DHA(1∶2),评估新物体识别和T迷宫奖赏的记忆,GC-MS检测躯体PUFAs浓度变化,qPCR检测脑内AChE、Axl、APP、Bace1、IL-6、TNF-α、CD11b、CD206、VDAC1、Caspase-3、Caspase-9和Bax的变化,ELISA试剂盒检测脑内Aβ的浓度。结果与模型组相比,EPA仅明显改善了斑马鱼的新物体识别能力,而DHA与EPA+DHA均恢复了新物体识别和T迷宫中的记忆。给予EPA、DHA和EPA+DHA均明显抑制了Aβ的蛋白浓度变化以及IL-6、CD206、Caspase-3、Caspase-9、Bax和AChE的mRNA表达,EPA和DHA均明显抑制了Bace1、APP和TNF-α的mRNA表达。DHA和EPA+DHA还明显降低了Axl和VDAC1的mRNA表达。结论EPA+DHA的组合对Al 3+诱导斑马鱼AD模型的记忆和认知障碍具有更好的改善作用,其作用机制可能通过抑制脑内细胞凋亡情况来改善记忆和认知障碍。
Aim To use the AD model to compare and study the mechanisms of EPA,DHA,the omega-3 polyunsaturated fatty acids,and their combination in improving cognitive impairment and neuroinflammation.Methods Zebra fish AD model was induced by Al 3+,fed with EPA,DHA or EPA+DHA(1∶2).New object recognition(NOR)and T-maze reward were used to evaluated the memory,GC-MS was used to detect PUFAs concentration changes in body,qPCR was applied to detect the changes of AChE,Axl,APP,Bace1,IL-6,TNF-α,CD11b,CD206,VDAC1,caspase-3,caspase-9 and Bax in brain,ELISA kit was employed to detect brain Aβconcentration.Results Compared with the model group,EPA only significantly improved zebra fish NOR ability,while DHA and EPA+DHA both restored NOR and memory in the T-maze.EPA,DHA and EPA+DHA significantly inhibited Aβprotein concentration change and mRNA expression of IL-6,CD206,caspase-3,caspase-9,Bax,and AChE.EPA and DHA significantly inhibited Bace1,APP,and TNF-αmRNA expression.DHA and EPA+DHA significantly reduced Axl and VDAC1 mRNA expression.Conclusions The combination of EPA and DHA has a better effect on memory and cognitive impairment in zebra fish AD model induced by Al 3+,and its mechanism may be improving memory and cognitive impairment via inhibiting brain cell apoptosis.
作者
黄城益
邓淑怡
宋采
HUANG Cheng-yi;DENG Shu-yi;SONG Cai(College of Food Science and Technology Guangdong Ocean University,Zhanjiang Guangdong 524088,China;Institute of Shenzhen,Guangdong Ocean University,Shenzhen 518117,China)
出处
《中国药理学通报》
CAS
CSCD
北大核心
2024年第4期701-709,共9页
Chinese Pharmacological Bulletin
基金
广东省基础与应用基础研究基金项目(No 2021A1515011579)
深圳市科技计划(国际合作研究)项目(No GJHZ20190823111414825)。